Table 3. Multiple comparisons of femoropopliteal treatment location and clinical outcomes.
| Adjusted hazard ratio (95% confidence interval) | p-value | |
|---|---|---|
| Target lesion revascularisation | ||
| PA vs SFA | 0.82 (0.47-1.42) | 0.667 |
| SFA/PA vs SFA | 1.48 (1.09-2.00) | 0.008 |
| SFA/PA vs PA | 1.80 (1.00-3.27) | 0.052 |
| Major amputation | ||
| PA vs SFA | 3.39 (0.61-18.70) | 0.213 |
| SFA/PA vs SFA | 1.36 (0.34-5.42) | 0.859 |
| SFA/PA vs PA | 0.40 (0.06-2.92) | 0.525 |
| Loss of patency | ||
| PA vs SFA | 0.93 (0.70-1.25) | 0.841 |
| SFA/PA vs SFA | 1.30 (1.08-1.56) | 0.002 |
| SFA/PA vs PA | 1.39 (1.01-1.92) | 0.043 |
| Major adverse limb event | ||
| PA vs SFA | 0.87 (0.51-1.48) | 0.809 |
| SFA/PA vs SFA | 1.43 (1.06-1.92) | 0.015 |
| SFA/PA vs PA | 1.64 (0.92-2.90) | 0.106 |
| All-cause death* | ||
| PA vs SFA | 1.31 (0.60-2.84) | 0.695 |
| SFA/PA vs SFA | 1.07 (0.62-1.85) | 0.957 |
| SFA/PA vs PA | 0.82 (0.33-2.02) | 0.858 |
| *Analysis based on patient-level data. PA: popliteal artery; SFA: superficial femoral artery | ||